Specialty Pharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063502
  • May 2021
  • Pharmaceuticals
  • 122 Pages
The global Specialty Pharmaceuticals market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Specialty Pharmaceuticals market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Specialty Pharmaceuticals market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Specialty Pharmaceuticals market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Pfizer Inc., Amgen Inc., AstraZeneca, Teva Pharmaceutical Industries Ltd., Otsuka America Pharmaceutical, Inc., rEVO Biologics, Inc., AbbVie Inc., Gilead, Janssen Global Services, LLC, Celgene, Ginger.io., Lonza, ObsEva, Zealand Pharma, Polyphor, Aclaris Therapeutics, Allergan, Supernus Pharma, Taiho Pharmaceutical, AMAG Pharmaceuticals, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Specialty Pharmaceuticals market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Specialty Pharmaceuticals market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Specialty Pharmaceuticals market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Specialty Pharmaceuticals market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Specialty Pharmaceuticals Market:
The Specialty Pharmaceuticals market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Pfizer Inc., Amgen Inc., AstraZeneca, Teva Pharmaceutical Industries Ltd., Otsuka America Pharmaceutical, Inc., rEVO Biologics, Inc., AbbVie Inc., Gilead, Janssen Global Services, LLC, Celgene, Ginger.io., Lonza, ObsEva, Zealand Pharma, Polyphor, Aclaris Therapeutics, Allergan, Supernus Pharma, Taiho Pharmaceutical, AMAG Pharmaceuticals, Inc.

Specialty Pharmaceuticals Market Segment Analysis:
By Route of Administration
Oral
Parenteral
Transdermal
Therapeutic Area
Oncology
Inflammatory Conditions
Multiple sclerosis
Growth Hormone
Other Disease Conditions
Distribution Channel
Hospitals
Retail Pharmacies
Specialty Pharmacies
Mail Order

Geographic Coverage for Specialty Pharmaceuticals Market:
The market research report on global Specialty Pharmaceuticals market offers complete analysis across various regions across the world. The Specialty Pharmaceuticals market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Specialty Pharmaceuticals market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Specialty Pharmaceuticals Market Value and Forecast
  • US
  • Canada
Europe Specialty Pharmaceuticals Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Specialty Pharmaceuticals Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Specialty Pharmaceuticals Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Specialty Pharmaceuticals Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Specialty Pharmaceuticals market report:
  • The report provides key trends of the global Specialty Pharmaceuticals market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Specialty Pharmaceuticals industry
  • The report covers all the recent developments of the Specialty Pharmaceuticals market and helps to provide current industry updates
  • The report covers a detailed look over the global Specialty Pharmaceuticals Industry and provides with significant actionable insights
  • The Specialty Pharmaceuticals market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Specialty Pharmaceuticals market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Specialty Pharmaceuticals market
  • Comprehensive analysis of the Specialty Pharmaceuticals market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Specialty Pharmaceuticals market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Specialty Pharmaceuticals market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Specialty Pharmaceuticals market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Specialty Pharmaceuticals market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Specialty Pharmaceuticals market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Pfizer Inc.
  • Amgen Inc.
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd.
  • Otsuka America Pharmaceutical, Inc.
  • rEVO Biologics, Inc.
  • AbbVie Inc.
  • Gilead
  • Janssen Global Services, LLC
  • Celgene
  • Ginger.io.
  • Lonza
  • ObsEva
  • Zealand Pharma
  • Polyphor
  • Aclaris Therapeutics
  • Allergan
  • Supernus Pharma
  • Taiho Pharmaceutical
  • AMAG Pharmaceuticals, Inc.
  • Oral
  • Parenteral
  • Transdermal
  • Hospitals
  • Retail Pharmacies
  • Specialty Pharmacies
  • Mail Order

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Specialty Pharmaceuticals Market Snapshot
          2.1.1. Global Specialty Pharmaceuticals Market By Route of Administration,2019
               2.1.1.1.Oral
               2.1.1.2.Parenteral
               2.1.1.3.Transdermal
          2.1.2. Global Specialty Pharmaceuticals Market By Distribution Channel,2019
               2.1.2.1.Hospitals
               2.1.2.2.Retail Pharmacies
               2.1.2.3.Specialty Pharmacies
               2.1.2.4.Mail Order
          2.1.3. Global Specialty Pharmaceuticals Market By End-use,2019
          2.1.4. Global Specialty Pharmaceuticals Market By Geography,2019

3. Global Specialty Pharmaceuticals Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Route of Administration, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Route of Administration, 2020
     4.2. Global Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028

5. Global Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028

7. Global Specialty Pharmaceuticals Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Specialty Pharmaceuticals Market Analysis, 2018 – 2028 
          7.2.1. North America Specialty Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028
          7.2.3. North America Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Specialty Pharmaceuticals Market Analysis, 2018 – 2028 
          7.3.1.  Europe Specialty Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028
          7.3.3. Europe Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Specialty Pharmaceuticals Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Specialty Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028
          7.4.3. Asia Pacific Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Specialty Pharmaceuticals Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Specialty Pharmaceuticals Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028
          7.5.3. Latin America Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Specialty Pharmaceuticals Market Analysis, 2018 – 2028 
          7.6.1.  MEA Specialty Pharmaceuticals Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Specialty Pharmaceuticals Market Size (US$), By Route of Administration, 2018 – 2028
          7.6.3. MEA Specialty Pharmaceuticals Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Specialty Pharmaceuticals Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Specialty Pharmaceuticals Providers
        8.4.1 Pfizer Inc.
                8.4.1.1 Business Description
                8.4.1.2 Pfizer Inc. Geographic Operations
                8.4.1.3 Pfizer Inc. Financial Information
                8.4.1.4 Pfizer Inc. Product Positions/Portfolio
                8.4.1.5 Pfizer Inc. Key Developments
        8.4.2 Amgen Inc.
                8.4.2.1 Business Description
                8.4.2.2 Amgen Inc. Geographic Operations
                8.4.2.3 Amgen Inc. Financial Information
                8.4.2.4 Amgen Inc. Product Positions/Portfolio
                8.4.2.5 Amgen Inc. Key Developments
        8.4.3 AstraZeneca
                8.4.3.1 Business Description
                8.4.3.2 AstraZeneca Geographic Operations
                8.4.3.3 AstraZeneca Financial Information
                8.4.3.4 AstraZeneca Product Positions/Portfolio
                8.4.3.5 AstraZeneca Key Developments
        8.4.4 Teva Pharmaceutical Industries Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.4.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.4.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.4.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.5 Otsuka America Pharmaceutical, Inc.
                8.4.5.1 Business Description
                8.4.5.2 Otsuka America Pharmaceutical, Inc. Geographic Operations
                8.4.5.3 Otsuka America Pharmaceutical, Inc. Financial Information
                8.4.5.4 Otsuka America Pharmaceutical, Inc. Product Positions/Portfolio
                8.4.5.5 Otsuka America Pharmaceutical, Inc. Key Developments
        8.4.6 rEVO Biologics, Inc.
                8.4.6.1 Business Description
                8.4.6.2 rEVO Biologics, Inc. Geographic Operations
                8.4.6.3 rEVO Biologics, Inc. Financial Information
                8.4.6.4 rEVO Biologics, Inc. Product Positions/Portfolio
                8.4.6.5 rEVO Biologics, Inc. Key Developments
        8.4.7 AbbVie Inc.
                8.4.7.1 Business Description
                8.4.7.2 AbbVie Inc. Geographic Operations
                8.4.7.3 AbbVie Inc. Financial Information
                8.4.7.4 AbbVie Inc. Product Positions/Portfolio
                8.4.7.5 AbbVie Inc. Key Developments
        8.4.8 Gilead
                8.4.8.1 Business Description
                8.4.8.2 Gilead Geographic Operations
                8.4.8.3 Gilead Financial Information
                8.4.8.4 Gilead Product Positions/Portfolio
                8.4.8.5 Gilead Key Developments
        8.4.9 Janssen Global Services, LLC
                8.4.9.1 Business Description
                8.4.9.2 Janssen Global Services, LLC Geographic Operations
                8.4.9.3 Janssen Global Services, LLC Financial Information
                8.4.9.4 Janssen Global Services, LLC Product Positions/Portfolio
                8.4.9.5 Janssen Global Services, LLC Key Developments
        8.4.10 Celgene
                8.4.10.1 Business Description
                8.4.10.2 Celgene Geographic Operations
                8.4.10.3 Celgene Financial Information
                8.4.10.4 Celgene Product Positions/Portfolio
                8.4.10.5 Celgene Key Developments
        8.4.11 Ginger.io.
                8.4.11.1 Business Description
                8.4.11.2 Ginger.io. Geographic Operations
                8.4.11.3 Ginger.io. Financial Information
                8.4.11.4 Ginger.io. Product Positions/Portfolio
                8.4.11.5 Ginger.io. Key Developments
        8.4.12 Lonza
                8.4.12.1 Business Description
                8.4.12.2 Lonza Geographic Operations
                8.4.12.3 Lonza Financial Information
                8.4.12.4 Lonza Product Positions/Portfolio
                8.4.12.5 Lonza Key Developments
        8.4.13 ObsEva
                8.4.13.1 Business Description
                8.4.13.2 ObsEva Geographic Operations
                8.4.13.3 ObsEva Financial Information
                8.4.13.4 ObsEva Product Positions/Portfolio
                8.4.13.5 ObsEva Key Developments
        8.4.14 Zealand Pharma
                8.4.14.1 Business Description
                8.4.14.2 Zealand Pharma Geographic Operations
                8.4.14.3 Zealand Pharma Financial Information
                8.4.14.4 Zealand Pharma Product Positions/Portfolio
                8.4.14.5 Zealand Pharma Key Developments
        8.4.15 Polyphor
                8.4.15.1 Business Description
                8.4.15.2 Polyphor Geographic Operations
                8.4.15.3 Polyphor Financial Information
                8.4.15.4 Polyphor Product Positions/Portfolio
                8.4.15.5 Polyphor Key Developments
        8.4.16 Aclaris Therapeutics
                8.4.16.1 Business Description
                8.4.16.2 Aclaris Therapeutics Geographic Operations
                8.4.16.3 Aclaris Therapeutics Financial Information
                8.4.16.4 Aclaris Therapeutics Product Positions/Portfolio
                8.4.16.5 Aclaris Therapeutics Key Developments
        8.4.17 Allergan
                8.4.17.1 Business Description
                8.4.17.2 Allergan Geographic Operations
                8.4.17.3 Allergan Financial Information
                8.4.17.4 Allergan Product Positions/Portfolio
                8.4.17.5 Allergan Key Developments
        8.4.18 Supernus Pharma
                8.4.18.1 Business Description
                8.4.18.2 Supernus Pharma Geographic Operations
                8.4.18.3 Supernus Pharma Financial Information
                8.4.18.4 Supernus Pharma Product Positions/Portfolio
                8.4.18.5 Supernus Pharma Key Developments
        8.4.19 Taiho Pharmaceutical
                8.4.19.1 Business Description
                8.4.19.2 Taiho Pharmaceutical Geographic Operations
                8.4.19.3 Taiho Pharmaceutical Financial Information
                8.4.19.4 Taiho Pharmaceutical Product Positions/Portfolio
                8.4.19.5 Taiho Pharmaceutical Key Developments
        8.4.20 AMAG Pharmaceuticals, Inc.
                8.4.20.1 Business Description
                8.4.20.2 AMAG Pharmaceuticals, Inc. Geographic Operations
                8.4.20.3 AMAG Pharmaceuticals, Inc. Financial Information
                8.4.20.4 AMAG Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.20.5 AMAG Pharmaceuticals, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Specialty Pharmaceuticals Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Specialty Pharmaceuticals Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Specialty Pharmaceuticals Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Specialty Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Specialty Pharmaceuticals Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Specialty Pharmaceuticals Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Specialty Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Specialty Pharmaceuticals Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Specialty Pharmaceuticals Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Specialty Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Specialty Pharmaceuticals Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Specialty Pharmaceuticals Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Specialty Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Specialty Pharmaceuticals Market Revenue, By Route of Administration, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Specialty Pharmaceuticals Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Specialty Pharmaceuticals Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Specialty Pharmaceuticals: Market Segmentation 
FIG. 2 Global Specialty Pharmaceuticals Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Specialty Pharmaceuticals Market, By Route of Administration, 2019 (US$ Mn) 
FIG. 5 Global Specialty Pharmaceuticals Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Specialty Pharmaceuticals Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Specialty Pharmaceuticals Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Specialty Pharmaceuticals Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Specialty Pharmaceuticals Providers, 2019
FIG. 11 Global Specialty Pharmaceuticals Market Revenue Contribution, By Route of Administration, 2019 & 2028 (Value %) 
FIG. 12 Global Specialty Pharmaceuticals Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Specialty Pharmaceuticals Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Specialty Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Specialty Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Specialty Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Specialty Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Specialty Pharmaceuticals Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Specialty Pharmaceuticals market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Specialty Pharmaceuticals Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Specialty Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  North America Specialty Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  North America Specialty Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Europe Specialty Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Europe Specialty Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Europe Specialty Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Specialty Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Specialty Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Specialty Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Latin America Specialty Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Specialty Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Specialty Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  MEA Specialty Pharmaceuticals Market Value, By Segment1, 2018 – 2028
TABLE  MEA Specialty Pharmaceuticals Market Value, By Segment2, 2018 – 2028
TABLE  MEA Specialty Pharmaceuticals Market Value, By Country, 2018 – 2028
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amgen Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Otsuka America Pharmaceutical, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  rEVO Biologics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Janssen Global Services, LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celgene: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ginger.io.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lonza: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ObsEva: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zealand Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Polyphor: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aclaris Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergan: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Supernus Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Taiho Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AMAG Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Specialty Pharmaceuticals Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Specialty Pharmaceuticals Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Specialty Pharmaceuticals Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Specialty Pharmaceuticals Market, By Geography, 2019 (US$ Mn)
FIG.  Global Specialty Pharmaceuticals Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Specialty Pharmaceuticals Providers, 2016
FIG.  Global Specialty Pharmaceuticals Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Parenteral Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Transdermal Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Specialty Pharmaceuticals Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Specialty Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Mail Order Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Specialty Pharmaceuticals Market Value, 2018 – 2028, (US$ Mn)